You just read:

Yisheng Biopharma Starts Enrollment in Phase 1 Immuno-Oncology Clinical Trial of YS-ON-001 in Patients with Advanced Solid Tumors

News provided by

Yisheng Biopharma Co., Ltd.

May 01, 2017, 08:00 ET